Phase III PATENCY-2 trial of vonapanitase does not meet its coprimary endpoints March 29, 2019 No Comments
Tricida reports results from extension trial of TRC-101 in CKD patients with metabolic acidosis March 28, 2019 No Comments
Urovant Sciences launches international phase III COURAGE study of vibegron March 28, 2019 No Comments
New mutations in NPHP3 and NEK8 are associated with renal-hepatic-pancreatic dysplasia March 26, 2019 No Comments
Positive topline results presented from pivotal phase III EMPOWUR study of vibegron March 20, 2019 No Comments
Arch Biopartners receives approval for phase I study of Metablok in Australia March 20, 2019 No Comments
Veverimer phase III results for metabolic acidosis associated with chronic kidney disease March 15, 2019 No Comments
RSS